We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
1426
Fulcrum Therapeutics
FULC
$297M
-925
Closed -$26K
GBIO
1427
DELISTED
Generation Bio
GBIO
-130
Closed -$32K
GDDY icon
1428
GoDaddy
GDDY
$11.5B
-612
Closed -$42K
GERN icon
1429
Geron
GERN
$949M
-7,335
Closed -$10K
GEVO icon
1430
Gevo
GEVO
$382M
-1,990
Closed -$13K
LKFT
1431
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
-215
Closed -$11K
GMAB icon
1432
Genmab
GMAB
$19.5B
-1,105
Closed -$48K
GNRC icon
1433
Generac Holdings
GNRC
$12.5B
-19,814
Closed -$8.1M
GOSS icon
1434
Gossamer Bio
GOSS
$87M
-1,735
Closed -$21K
GQRE icon
1435
FlexShares Global Quality Real Estate Index Fund
GQRE
$421M
-1,014
Closed -$66K
GRFS
1436
Grifois
GRFS
$5.4B
-2,660
Closed -$38K
HALO icon
1437
Halozyme
HALO
$12.2B
-3,255
Closed -$132K
HCM icon
1438
HUTCHMED
HCM
$2.17B
-1,240
Closed -$45K
IBRX icon
1439
ImmunityBio
IBRX
$8.1B
-8,950
Closed -$87K
IDYA icon
1440
IDEAYA Biosciences
IDYA
$3.56B
-880
Closed -$22K
IGMS
1441
DELISTED
IGM Biosciences
IGMS
-585
Closed -$38K
NBP
1442
NovaBridge Biosciences American Depositary Shares
NBP
$202M
-960
Closed -$69K
IMUX icon
1443
Immunic
IMUX
$195M
-60
Closed -$5K
INO icon
1444
Inovio Pharmaceuticals
INO
$69M
-401
Closed -$34K
INSM icon
1445
Insmed
INSM
$28.6B
-2,635
Closed -$72K
INSP icon
1446
Inspire Medical Systems
INSP
$1.74B
-5,652
Closed -$1.32M
INVA icon
1447
Innoviva
INVA
$1.48B
-1,590
Closed -$26K
INZY
1448
DELISTED
Inozyme Pharma
INZY
-540
Closed -$6K
IRWD icon
1449
Ironwood Pharmaceuticals
IRWD
$714M
-3,725
Closed -$48K
ITOS
1450
DELISTED
iTeos Therapeutics
ITOS
-805
Closed -$21K

Similar funds

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.